There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Mothers with MS face longer diagnostic delays than women without children, especially those who are employed or single.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

A new study finds that in about one in 10 cases of multiple sclerosis, the body makes a distinct set of antibodies years before symptoms emerge. (Getty Images) A new study found that in about 10% ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

A generic version of multiple sclerosis drug Copaxone was introduced in 2015, but it has done little to lower drug costs for MS patients, NPR reported. Yearly costs for MS drugs can run as high as $50 ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Find out how combined chemical exposures and genetics may raise multiple sclerosis risk in new population research.

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...